Skip to content
Home/Companies/Biotech/Auron Therapeutics
Auron Therapeutics

Auron Therapeutics

Biotech·US·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns Auron Therapeutics?

Auron Therapeutics is currently owned by Apollo Health Ventures through Apollo Health Ventures Fund II (2021 vintage), since 2022.

Hand-verified · updated 2026-07-03

Apollo Health Ventures
Investor
Apollo Health Ventures
Apollo Health Ventures Fund II · 2021 · Life Sciences VC

Key facts

HQUnited States
SectorBiotech
StatusActive
Track Auron Therapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Auron Therapeutics?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Auron Therapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue